|
1
|
Crew KD and Neugut AI: Epidemiology of
gastric cancer. World J Gastroenterol. 12:354–362. 2006.
|
|
2
|
Crighton D and Ryan KM: Splicing
DNA-damage responses to tumor cell death. Biochim Biophys Acta.
1705:3–15. 2004.
|
|
3
|
Ryan KM, Phillips AC and Vousden KH:
Regulation and function of the p53 tumor suppressor protein. Curr
Opin Cell Biol. 13:332–337. 2001.
|
|
4
|
Feng Z, Zhang H, Levine AJ and Jin S: The
coordinate regulation of the p53 and mTOR pathways in cells. Proc
Natl Acad Sci USA. 102:8204–8209. 2005.
|
|
5
|
Crighton D, Wilkinson S, O’Prey J, Syed N,
Smith P, Harrison PR, Gasco M, Garrone O, Crook T and Ryan KM:
DRAM, a p53-induced modulator of autophagy, is critical for
apoptosis. Cell. 126:121–134. 2006.
|
|
6
|
Klionsky DJ and Emr SD: Autophagy as a
regulated pathway of cellular degradation. Science. 290:1717–1721.
2000.
|
|
7
|
Kerley-Hamilton JS, Pike AM, Hutchinson
JA, Freemantle SJ and Spinella MJ: The direct p53 target gene,
FLJ11259/DRAM, is a member of a novel family of transmembrane
proteins. Biochim Biophys Acta. 1769:209–219. 2007.
|
|
8
|
Crighton D, O’Prey J, Bell HS and Ryan KM:
p73 regulates DRAM-independent autophagy that does not contribute
to programmed cell death. Cell Death Differ. 14:1071–1079.
2007.
|
|
9
|
Alesci S, Ramsey WJ, Bornstein SR,
Chrousos GP, Hornsby PJ, Benvenga S, Trimarchi F and
Ehrhart-Bornstein M: Adenoviral vectors can impair adrenocortical
steroidogenesis: clinical implications for natural infections and
gene therapy. Proc Natl Acad Sci USA. 99:7484–7489. 2002.
|
|
10
|
Niemann A, Takatsuki A and Elsässer HP:
The lysosomotropic agent monodansylcadaverine also acts as a
solvent polarity probe. J Histochem Cytochem. 48:251–258. 2000.
|
|
11
|
Ikeda K, Monden T, Kanoh T, Tsujie M,
Izawa H, Haba A, Ohnishi T, Sekimoto M, Tomita N, Shiozaki H and
Monden M: Extraction and analysis of diagnostically useful proteins
from formalin-fixed, paraffin-embedded tissue sections. J Histochem
Cytochem. 46:397–403
|
|
12
|
Biederbick A, Kern HF and Elsässer HP:
Monodansylcadaverine (MDC) is a specific in vivo marker for
autophagic vacuoles. Eur J Cell Biol. 66:3–14. 1995.
|
|
13
|
Yoshimori T: Autophagy: a regulated bulk
degradation process inside cells. Biochem Biophys Res Commun.
313:453–458. 2004.
|
|
14
|
Maiuri MC, Tasdemir E, Criollo A, Morselli
E, Vicencio JM, Carnuccio R and Kroemer G: Control of autophagy by
oncogenes and tumor suppressor genes. Cell Death Differ. 16:87–93.
2009.
|
|
15
|
Morselli E, Galluzzi L, Kepp O, Vicencio
JM, Criollo A, Maiuri MC and Kroemer G: Anti- and pro-tumor
functions of autophagy. Biochim Biophys Acta. 1793:1524–1532.
2009.
|
|
16
|
White E and DiPaola RS: The double-edged
sword of autophagy modulation in cancer. Clin Cancer Res.
15:5308–5316. 2009.
|
|
17
|
Soussi T: p53 alterations in human cancer:
more questions than answers. Oncogene. 26:2145–2156. 2007.
|
|
18
|
Soussi T and Lozano G: p53 mutation
heterogeneity in cancer. Biochem Biophys Res Commun. 331:834–842.
2005.
|
|
19
|
Liang XH, Jackson S, Seaman M, Brown K,
Kempkes B, Hibshoosh H and Levine B: Induction of autophagy and
inhibition of tumorigenesis by beclin 1. Nature. 402:672–676.
1999.
|
|
20
|
Yue Z, Jin S, Yang C, Levine AJ and Heintz
N: Beclin 1, an autophagy gene essential for early embryonic
development, is a haploinsufficient tumor suppressor. Proc Natl
Acad Sci USA. 100:15077–15082. 2003.
|
|
21
|
Zeng X, Overmeyer JH and Maltese WA:
Functional specificity of the mammalian Beclin-Vps34 PI 3-kinase
complex in macroautophagy versus endocytosis and lysosomal enzyme
trafficking. J Cell Sci. 119:259–270. 2006.
|
|
22
|
Lum JJ, DeBerardinis RJ and Thompson CB:
Autophagy in metazoans: cell survival in the land of plenty
(review). Nat Rev Mol Cell Biol. 6:439–448. 2005.
|
|
23
|
Aita VM, Liang XH, Murty VV, Pincus DL, Yu
W, Cayanis E, Kalachikov S, Gilliam TC and Levine B: Cloning and
genomic organization of Beclin 1, a candidate tumor suppressor gene
on chromosome 17q21. Genomics. 59:59–65. 1999.
|
|
24
|
Qu X, Yu J, Bhagat G, Furuya N, Hibshoosh
H, Troxel A, Rosen J, Eskelinen EL, Mizushima N, Ohsumi Y,
Cattoretti G and Levine B: Promotion of tumorigenesis by
heterozygous disruption of the beclin 1 autophagy gene. J Clin
Invest. 112:1809–1820. 2003.
|
|
25
|
Pattingre S, Tassa A, Qu X, Garuti R,
Liang XH, Mizushima N, Packer M, Schneider MD and Levine B: Bcl-2
antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell.
122:927–939. 2005.
|
|
26
|
Hoyer-Hansen M, Bastholm L, Szyniarowski
P, Campanella M, Szabadkai G, Farkas T, Bianchi K, Fehrenbacher N,
Elling F, Rizzuto R, Mathiasen IS and Jäättelä M: Control of
macroautophagy by calcium, calmodulindependent kinase kinase-beta,
and Bcl-2. Mol Cell. 25:193–205. 2007.
|
|
27
|
Oberstein A, Jeffrey PD and Shi Y: Crystal
structure of the Bcl-XL-Beclin 1 peptide complex: Beclin 1 is a
novel BH3-only protein. J Biol Chem. 282:13123–13132. 2007.
|
|
28
|
Le NT and Richardson DR: Potent iron
chelators increase the mRNA levels of the universal
cyclin-dependent kinase inhibitor p21(CIP1/WAF1), but paradoxically
inhibit its translation: a potential mechanism of cell cycle
dysregulation. Carcinogenesis. 24:1045–1058. 2003.
|
